Evidence map›Paper›PMID 39676657›Full record

ReviewNucleic acids research2025

Navigating triplet repeats sequencing: concepts, methodological challenges and perspective for Huntington's disease.

Simone Maestri, Davide Scalzo, Gianluca Damaggio, Martina Zobel, Dario Besusso, Elena Cattaneo

Abstract readReview
In one paragraph

Review in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Towards AI-driven prediction ofJournal of Huntington's disease · 2026
    Article
  2. Article
  3. Article
  4. The novel (TCTG)Human genomics · 2026
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Simone MaestriDepartment of Biosciences, University of Milan, Street Giovanni Celoria, 26, 20133, Milan, Italy.ORCID 0000-0002-1192-0684
Davide ScalzoDepartment of Biosciences, University of Milan, Street Giovanni Celoria, 26, 20133, Milan, Italy.ORCID 0009-0006-6020-1287
Gianluca DamaggioDepartment of Biosciences, University of Milan, Street Giovanni Celoria, 26, 20133, Milan, Italy.ORCID 0000-0001-6567-0660
Martina ZobelDepartment of Biosciences, University of Milan, Street Giovanni Celoria, 26, 20133, Milan, Italy.ORCID 0009-0000-4812-3809
Dario BesussoDepartment of Biosciences, University of Milan, Street Giovanni Celoria, 26, 20133, Milan, Italy.ORCID 0000-0001-9793-9644
Elena CattaneoDepartment of Biosciences, University of Milan, Street Giovanni Celoria, 26, 20133, Milan, Italy.ORCID 0000-0002-0755-4917

Funding

C.H.D.I. Foundation JSC A11103European Research Council, Advanced Grant 742436Fondazione Telethon GMR23T1059Leslie Gehry Prize for Innovation in Science from the Hereditary Disease FoundationMinistero dell'Istruzione, dell'Università e della Ricerca 2022LBENTHNSC-Reconstruct Consortium, European Union's Horizon 2020 Research and Innovation Program 874758
6 · The paper itself

Abstract

The accurate characterization of triplet repeats, especially the overrepresented CAG repeats, is increasingly relevant for several reasons. First, germline expansion of CAG repeats above a gene-specific threshold causes multiple neurodegenerative disorders; for instance, Huntington's disease (HD) is triggered by >36 CAG repeats in the huntingtin (HTT) gene. Second, extreme expansions up to 800 CAG repeats have been found in specific cell types affected by the disease. Third, synonymous single nucleotide variants within the CAG repeat stretch influence the age of disease onset. Thus, new sequencing-based protocols that profile both the length and the exact nucleotide sequence of triplet repeats are crucial. Various strategies to enrich the target gene over the background, along with sequencing platforms and bioinformatic pipelines, are under development. This review discusses the concepts, challenges, and methodological opportunities for analyzing triplet repeats, using HD as a case study. Starting with traditional approaches, we will explore how sequencing-based methods have evolved to meet increasing scientific demands. We will also highlight experimental and bioinformatic challenges, aiming to provide a guide for accurate triplet repeat characterization for diagnostic and therapeutic purposes.

Indexed as

Huntington DiseaseSequence Analysis, DNATrinucleotide Repeat ExpansionTrinucleotide RepeatsComputational BiologyHigh-Throughput Nucleotide SequencingHumansHuntingtin ProteinHTT protein, humanHuntingtin Protein

Identifiers

PMID39676657
PMCPMC11724279

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.